FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.2876
-0.0305 (-9.59%)
At close: May 30, 2025, 4:00 PM
0.2998
+0.0122 (4.24%)
After-hours: May 30, 2025, 7:59 PM EDT
FibroGen Employees
FibroGen had 225 employees as of December 31, 2024. The number of employees decreased by 261 or -53.70% compared to the previous year.
Employees
225
Change (1Y)
-261
Growth (1Y)
-53.70%
Revenue / Employee
$31,093
Profits / Employee
-$44,476
Market Cap
29.06M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
FGEN News
- 18 days ago - FibroGen, Inc. (FGEN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 22 days ago - Duchenne Muscular Dystrophy (DMD) Pipeline Insight Report 2025, Featuring Analysis of Vamorolone (Santhera), Givinostat (Italfarmaco), and Pamrevlumab (Fibrogen) - GlobeNewsWire
- 25 days ago - FibroGen to Report First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - FibroGen, Inc. (FGEN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire